[시장보고서]맞춤형 영양(Personalized Nutrition) 시장 예측(-2030년) : 제품(제품, 서비스, 디지털 툴), 용도(일반 라이프스타일, 미용, 피부 및 장수, 체중 관리 및 대사 건강), 최종사용자, 퍼스널라이제이션 기준, 유형, 지역별

맞춤형 영양(Personalized Nutrition) 시장 예측(-2030년) : 제품(제품, 서비스, 디지털 툴), 용도(일반 라이프스타일, 미용, 피부 및 장수, 체중 관리 및 대사 건강), 최종사용자, 퍼스널라이제이션 기준, 유형, 지역별

Personalized Nutrition Market by Product (Products, Services, Digital Tools), Application (General Lifestyle, Beauty, Skin & Longevity, Weight Management & Metabolic Health), End-use, Personalization Basis, Type, & Region - Global Forecast to 2030

상품코드 : 1858526 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 10월

페이지 정보 : 영문 316 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,351,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,876,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 12,104,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,852,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 맞춤형 영양(Personalized Nutrition) 시장 규모는 2025년 157억 9,000만 달러에서 예측 기간 중 CAGR 14.4%로 추이하며, 2030년에는 309억 4,000만 달러에 달할 것으로 예측됩니다.

맞춤형 영양 시장은 건강 인식 증가, 예방 의료의 중요성, 유전체학 및 디지털 헬스 기술의 발전 등을 배경으로 빠르게 성장하고 있습니다. 소비자들은 자신의 유전정보, 생활습관, 건강상태에 맞는 맞춤형 식단, 보충제, 기능성 식품을 찾는 경향이 강해지고 있습니다.

조사 범위
조사 대상 연도	2025-2030년
기준연도	2024년
예측 기간	2025-2030년
단위	금액(달러)·수량(대수)
부문별	제품, 최종사용자, 유형, 퍼스널라이제이션 기준, 용도, 지역별
대상 지역	북미, 유럽, 아시아태평양, 남미, 기타 지역

북미는 높은 의료비 지출과 높은 디지털 솔루션 도입률로 시장을 선도하고 있으며, 아시아태평양은 도시화 진전과 만성질환 증가를 배경으로 가장 빠르게 성장하는 지역으로 꼽히고 있습니다. 주요 기업은 식품, 뉴트리슈티컬(건강식품), 기술 분야의 기업으로 DNA 검사, 모바일 앱, 웨어러블 연동 등의 서비스를 제공합니다. 그러나 높은 비용과 복잡한 규제 환경은 시장 확대의 과제로 남아있습니다.

"뷰티, 스킨케어, 장수 부문이 예측 기간 중 높은 CAGR을 나타낼 것으로 예측됩니다."

이는 웰니스-미용-예방의료의 융합이 진행되고 있기 때문입니다. 소비자들은 외적인 아름다움뿐만 아니라 내면의 건강을 중시하는 종합적인 접근 방식으로 전환하고 있으며, 영양은 피부 탄력, 모발 강도, 건강한 노화를 지원하는 핵심적인 역할을 하고 있습니다. 또한 영양유전체학, 마이크로바이옴 분석, 디지털 진단의 발전으로 기업은 개인별 맞춤형 제품을 개발할 수 있게 되었고, 예를 들어 콜라겐 함유 보충제, 항산화 성분 함유 제제, 개별적으로 배합된 비타민 블렌드 등 개인별 맞춤형 제품을 개발할 수 있게 되었습니다. 특히 밀레니얼 세대와 Z세대는 일상적인 셀프 케어에 영양을 접목한 예방적 뷰티를 추구하고, 노년층은 삶의 질을 유지하기 위한 장수 지향적 솔루션을 원하고 있습니다.

"개인화 기반별로는 마이크로바이옴 기반 부문이 예측 기간 중 괄목할 만한 CAGR을 나타낼 것으로 예측됩니다."

장내 환경과 면역, 대사, 정신건강, 피부 건강의 연관성을 보여주는 과학적 증거가 증가함에 따라 마이크로바이옴을 타겟으로 한 솔루션에 대한 소비자의 관심이 빠르게 증가하고 있습니다. 개개인의 마이크로바이옴은 고유하므로 기업은 첨단 시퀀싱 기술과 AI 분석을 활용하여 각 개인의 장내 프로파일을 기반으로 한 보충제, 프로바이오틱스, 프리바이오틱스, 기능성 식품을 제공합니다. 또한 비만, 당뇨병, 소화기 질환 등 생활습관병 증가로 인해 자연적이고 예방적이며 과학적으로 근거가 있는 접근법으로 마이크로바이옴 기반 제품에 대한 수요가 증가하고 있습니다. 또한 집에서 사용할 수 있는 마이크로바이옴 검사 키트, 디지털 플랫폼과의 통합, 실시간 데이터 수집을 통한 식단 제안과 같은 혁신이 이 부문의 성장을 가속하고 있습니다.

"아시아태평양이 예측 기간 중 가장 빠른 성장률을 보일 것으로 예상"

그 배경에는 급속한 도시화, 가처분 소득 증가, 중산층의 확대가 있으며, 이는 예방 의료 및 웰니스에 대한 관심 증가를 지원하고 있습니다. 또한 이 지역에서는 당뇨병, 비만, 심혈관 질환 등 생활습관병이 증가하고 있으며, 식생활과 건강을 연계하는 문화적 전통이 강하게 남아있어 맞춤형 영양 솔루션에 적합한 시장 환경이 형성되어 있습니다. 중국, 일본, 한국, 인도 등의 국가에서는 디지털 건강 플랫폼, 웨어러블 기기, 가정용 검사 키트를 통해 개인 맞춤형 식단 및 보충제 제안을 받아들이는 움직임이 확대되고 있습니다. 특히 일본과 한국은 영양유전체학, 마이크로바이옴 검사, 기능성 식품의 통합이 진행되고 있으며, 중국에서는 E-commerce 다소 D2C로 개인화 제품 수요가 급증하고 있습니다. 인도와 동남아시아도 영양 관련 질환에 대한 인식 개선과 모바일 건강 앱의 보급으로 새로운 성장 거점이 되고 있습니다.

세계의 맞춤형 영양(Personalized Nutrition) 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인의 분석, 기술·특허의 동향, 법규제 환경, 사례 연구, 시장 규모 추이·예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

밸류체인 분석
고객 사업에 영향을 미치는 동향/혼란
가격 분석
에코시스템 분석
기술 분석
특허 분석
무역 분석
2025-2026년의 주요 컨퍼런스와 이벤트
규제 상황
Porter's Five Forces 분석
주요 이해관계자와 구입 기준
투자와 자금조달 시나리오
사례 연구 분석
퍼스널라이즈 영양 시장에 대한 관세의 영향

제7장 맞춤형 영양 시장 : 솔루션 유형별

제품
- 맞춤형 보충제
- 맞춤형 기능성 식품
서비스
- 검사·진단
- 코칭 및 영양사 카운셀링
- 기업용 웰니스 및 보험 제휴 프로그램
디지털 툴/플랫폼
- 모바일 앱
- 웨어러블 디바이스
- 온라인 플랫폼
- AI 코치

제8장 맞춤형 영양 시장 : 유형별

액티브
스탠다드

제9장 맞춤형 영양 시장 : 퍼스널라이제이션 기준별

영양유전체학
마이크로바이옴 기반
바이오마커
웨어러블 기반
행동·식사 기록 기반
라이프스타일 기반

제10장 맞춤형 영양 시장 : 용도별

일반적 라이프스타일
스포츠 & 피트니스 퍼포먼스
체중 관리·대사 건강
임상 영양·질환 관리
라이프 스테이지·특정 집단
미용, 스킨케어, 장수

제11장 맞춤형 영양 시장 : 최종사용자별

일반소비자용
환자/의료 이용자
스포츠 & 피트니스
기업·보험 회사

제12장 맞춤형 영양 시장 : 비즈니스 모델별(정성 분석)

DIRECT CONSUMERS ONE-TIME PURCHASE
서브스크립션
B2B/라이선싱

제13장 맞춤형 영양 시장 : 지역별

북미
- 미국
- 캐나다
- 멕시코
아시아태평양
- 중국
- 일본
- 인도
- 호주와 뉴질랜드
- 기타
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 네덜란드
- 기타
남미
- 아르헨티나
- 브라질
- 기타
기타 지역
- 아프리카
- 중동

제14장 경쟁 구도

개요
주요 참여 기업의 전략/강점
매출 분석
시장 점유율 분석
기업 평가와 재무 매트릭스
브랜드/제품 비교
- ABBOTT
- MEDTRONIC
- NESTLE
- PRENETICS
- ZOE
기업 평가 매트릭스 : 주요 기업
기업 평가 매트릭스 : 스타트업/중소기업
경쟁 벤치마킹 : 스타트업/중소기업
경쟁 시나리오와 동향

제15장 기업 개요

제품 기업
서비스 기업
기타 기업
- INSIDE TRACKER
- NUTRIGENOMIX
- SUGGESTIC
- LEVELS
- OVIVA
- NOOM
- CAREPREDICT
- SELFDECODE
- NUTRIGENIE
- SEASON HEALTH
- ALBA HEALTH

제16장 인접 시장과 관련 시장

제17장 부록

KSA

영문 목차

영문목차

The market for personalized nutrition is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% during the forecast period. The personalized nutrition market is expanding rapidly, driven by rising consumer awareness of health, preventive healthcare, and technological advancements in genomics and digital health platforms. Consumers increasingly demand customized diet plans, supplements, and functional foods tailored to individual genetics, lifestyle, and health conditions.

Scope of the Report
Years Considered for the Study	2025-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD) and Volume (Units sold)
Segments	By Product, end-use, type, personalization basis, application, and region
Regions covered	North America, Europe, Asia Pacific, South America, and Rest of the World (RoW)

North America leads due to its high healthcare spending and the adoption of digital solutions, while the Asia Pacific is the fastest-growing region, fueled by urbanization and the prevalence of chronic diseases. Key players include food, nutraceutical, and tech companies offering DNA-based testing, mobile apps, and wearable integration. Despite opportunities, high costs and regulatory complexities remain challenges to market growth.

"The beauty, skin, & longevity application segment is projected to register a significant CAGR during the forecast period."

The beauty, skin, & longevity segment is emerging as the fastest-growing application within the personalized nutrition market, fueled by the rising convergence of wellness, aesthetics, and preventative healthcare. Consumers are increasingly shifting toward holistic approaches that address not only external beauty but also internal health, with nutrition playing a central role in supporting skin vitality, hair strength, and healthy aging. Advances in nutrigenomics, microbiome analysis, and digital diagnostics are enabling companies to create tailored solutions such as collagen-based supplements, antioxidant-rich formulations, and personalized vitamin blends that cater to individual needs for skin elasticity, hydration, and anti-aging benefits. Younger demographics, particularly millennials and Gen Z, are driving demand for preventive beauty solutions that integrate nutrition into daily self-care routines, while aging populations are seeking longevity-focused interventions to maintain quality of life.

"By personalization basis, the microbiome-based personalization segment is projected to witness a significant CAGR during the forecast period."

Growing scientific evidence linking gut health with immunity, metabolic function, mental wellbeing, and skin vitality has created strong consumer interest in microbiome-targeted solutions. With the human microbiome being unique to each individual, companies are leveraging advanced sequencing technologies and AI-driven analysis to provide customized dietary supplements, probiotics, prebiotics, and functional foods tailored to specific microbiome profiles. Rising incidence of lifestyle-related disorders, such as obesity, diabetes, and gastrointestinal issues, is further fueling demand for microbiome-based interventions as consumers look for natural, preventive, and scientifically validated options. The segment also benefits from rapid innovation, including at-home microbiome testing kits, integration with digital platforms, and real-time data collection that translates into actionable dietary recommendations.

"Asia Pacific is expected to exhibit the fastest growth rate during the forecast period."

The Asia Pacific (APAC) region is projected to be the fastest-growing market for personalized nutrition between 2025 and 2030, driven by rapid urbanization, rising disposable incomes, and a growing middle-class population increasingly focused on preventive healthcare and wellness. The region faces a dual challenge of escalating lifestyle-related diseases such as diabetes, obesity, and cardiovascular disorders, alongside strong cultural traditions linking diet with health, making it a fertile ground for personalized solutions. Consumers in countries like China, Japan, South Korea, and India are embracing digital health platforms, wearable devices, and at-home testing kits that provide customized dietary and supplement recommendations. Japan and South Korea lead in technological adoption, with advanced integration of nutrigenomics, microbiome testing, and functional foods, while China is seeing a surge in demand through e-commerce and direct-to-consumer personalized nutrition products. India and Southeast Asia are emerging hotspots due to rising awareness of nutrition-related disorders and the increasing penetration of mobile health apps.

In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the personalized nutrition market:

By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
By Designation: CXOs - 20%, Managers - 50%, Executives- 30%
By Region: North America - 25%, Europe - 30%, Asia Pacific - 20%, South America - 15%, and Rest of the World -10%

Prominent companies in the market include Abbott (US), Nestle Health Science (Switzerland), Medtronic (Ireland/US operations), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (US), Nutrigenomix (Canada), and Nature's Way (US).

Other players include Rootine (US), Sun Genomics (US), Seed Health (US), EatLove (US), Suggestic (US), Noom (US), Oviva (Switzerland/UK), SelfDecode (US), GenoPalate (US), Orig3n (US), Superpower (US), Alba Health (US), Season Health (US), Levels (US), Nutripal (India), Nutrigenie (US), myDNA (Australia), CarePredict (US), and Thryve (US).

Research Coverage:

This research report categorizes the personalized nutrition market by product (products, services, digital tools/platforms), application (general lifestyle, weight management & metabolic health, sports & fitness performance, clinical nutrition & disease management, life-stage & special populations, beauty, skin, & longevity), personalization basis (general lifestyle genetic/nutrigenomic, microbiome-based, biomarker/blood-based, physiological/wearable-based, behavioral & dietary log-based, demographic/lifestyle-based), end-use (direct consumers, patient, sports & fitness users, corporate & insurers), type (standard, active), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the market's growth. A detailed analysis of the key industry players has been done to provide insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments associated with the personalized nutrition market. This report covers a competitive analysis of upcoming startups in the personalized nutrition market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem and market mapping, patent analysis, and regulatory landscape, among others.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall personalized nutrition market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

Analysis of key drivers (shift in consumer preferences due to the rise in health awareness), restraints (inflated cost of personalized testing and nutrition plans), opportunities (increasing innovations and advancements in technologies), and challenges (presence of regulations in the personalized nutrition market) influencing the growth of the personalized nutrition market.
New Product Launch/Innovation: Detailed insights into research & development activities and new product launches in the personalized nutrition market.
Market Development: Comprehensive information about lucrative markets - the report analyzes the personalized nutrition across varied regions.
Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the personalized nutrition market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product food prints of leading players such as Abbott (US), Nestle Health Science (Switzerland), Medtronic (Ireland/USA operations), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (US), Nutrigenomix (Canada), Nature's Way (US), and other players in the personalized nutrition market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 UNITS CONSIDERED
- 1.5.1 CURRENCY/VALUE UNIT
- 1.5.2 VOLUME UNIT
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key data from primary sources
  - 2.1.2.2 Key insights from industry experts
  - 2.1.2.3 Breakdown of primary profiles
2.2 MARKET SIZE ESTIMATION
- 2.2.1 APPROACH ONE-BOTTOM-UP (BASED ON SOLUTION TYPE, BY REGION)
- 2.2.2 APPROACH TWO-TOP-DOWN (BASED ON GLOBAL MARKET)
- 2.2.3 SUPPLY-SIDE ANALYSIS
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES FOR KEY PLAYERS IN PERSONALIZED NUTRITION MARKET
4.2 ASIA PACIFIC PERSONALIZED NUTRITION MARKET, BY SOLUTION TYPE AND COUNTRY
4.3 PERSONALIZED NUTRITION MARKET, BY SOLUTION TYPE AND REGION
4.4 PERSONALIZED NUTRITION MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
- 5.2.1 RISING PREVALENCE OF CHRONIC DISEASES
- 5.2.2 SHIFT IN CONSUMER PREFERENCES DUE TO INCREASING FOCUS ON HEALTH
5.3 MARKET DYNAMICS
- 5.3.1 DRIVERS
  - 5.3.1.1 Rising healthcare burden due to chronic ailments
  - 5.3.1.2 Surge in elderly population and their growing use of dietary supplements
  - 5.3.1.3 Technological advances in omics, wearables, and AI to enable deeper, real-time personalized nutrition insights
  - 5.3.1.4 Preventive healthcare adoption by corporates, insurers, and providers to integrate personalized nutrition into systemic care
  - 5.3.1.5 Growing trend of digital healthcare
- 5.3.2 RESTRAINTS
  - 5.3.2.1 High costs of active measurement tests and supplements limiting mass-market affordability and adoption
  - 5.3.2.2 Regulatory complexity and restrictions on health claims hindering innovation and marketing effectiveness
- 5.3.3 OPPORTUNITIES
  - 5.3.3.1 Rising adoption of digital health tools
  - 5.3.3.2 Expansion into corporate wellness and insurer-backed preventive healthcare programs
- 5.3.4 CHALLENGES
  - 5.3.4.1 Scaling personalization across geographies due to cultural, dietary, and infrastructure differences
  - 5.3.4.2 Consumer engagement and retention due to churning in subscription models
5.4 IMPACT OF GENERATIVE AI ON PERSONALIZED NUTRITION MARKET
- 5.4.1 USE OF GEN AI IN PERSONALIZED NUTRITION MARKET
- 5.4.2 CASE STUDY ANALYSIS
  - 5.4.2.1 ZOE's Gen AI-Driven Nutrition Coaching Platform
  - 5.4.2.2 AI-Enhanced CGM Insights (Lingo Platform)
  - 5.4.2.3 Viome's AI-driven Personalized Supplement Formulation
- 5.4.3 IMPACT OF AI ON PERSONALIZED NUTRITION MARKET
- 5.4.4 IMPACT OF GEN AI ON ADJACENT ECOSYSTEM

6 INDUSTRY TRENDS

6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
- 6.2.1 SAMPLING
- 6.2.2 TESTING AND ASSESSMENT
- 6.2.3 INTERPRETATION & RECOMMENDATION
- 6.2.4 END USE
6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
6.4 PRICING ANALYSIS
- 6.4.1 AVERAGE SELLING PRICE OF NUTRITION TYPES, BY KEY PLAYER, 2024
- 6.4.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2030
6.5 ECOSYSTEM ANALYSIS
- 6.5.1 DEMAND-SIDE
- 6.5.2 SUPPLY-SIDE
6.6 TECHNOLOGY ANALYSIS
- 6.6.1 KEY TECHNOLOGIES
  - 6.6.1.1 Next-generation Sequencing
  - 6.6.1.2 16S rRNA & Metagenomic Sequencing
- 6.6.2 COMPLEMENTARY TECHNOLOGIES
  - 6.6.2.1 Continuous Glucose Monitoring
  - 6.6.2.2 AI/ML Nutrition Platforms
- 6.6.3 ADJACENT TECHNOLOGIES
  - 6.6.3.1 Telehealth & Virtual Nutrition Platforms
  - 6.6.3.2 3D Food Printing & Functional Food Tech
6.7 PATENT ANALYSIS
6.8 TRADE ANALYSIS
- 6.8.1 IMPORT SCENARIO OF HS CODE 3822
- 6.8.2 EXPORT SCENARIO OF HS CODE 3822
6.9 KEY CONFERENCES AND EVENTS, 2025-2026
6.10 REGULATORY LANDSCAPE
- 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 6.10.2 REGULATORY FRAMEWORK
  - 6.10.2.1 North America
    - 6.10.2.1.1 Canada
    - 6.10.2.1.2 US
    - 6.10.2.1.3 Mexico
- 6.10.3 EUROPEAN UNION REGULATIONS
  - 6.10.3.1 Asia Pacific
    - 6.10.3.1.1 China
    - 6.10.3.1.2 India
    - 6.10.3.1.3 Australia & New Zealand
  - 6.10.3.2 South America
    - 6.10.3.2.1 Brazil
    - 6.10.3.2.2 Argentina
  - 6.10.3.3 AFRICA
    - 6.10.3.3.1 Functional foods
    - 6.10.3.3.2 Dietary supplements
    - 6.10.3.3.3 Registrations in South Africa
    - 6.10.3.3.4 Composition of supplements in South Africa
  - 6.10.3.4 MIDDLE EAST
6.11 PORTER'S FIVE FORCES ANALYSIS
- 6.11.1 THREAT OF NEW ENTRANTS
- 6.11.2 THREAT OF SUBSTITUTES
- 6.11.3 BARGAINING POWER OF SUPPLIERS
- 6.11.4 BARGAINING POWER OF BUYERS
- 6.11.5 INTENSITY OF COMPETITIVE RIVALRY
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
- 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 6.12.2 BUYING CRITERIA
6.13 INVESTMENT AND FUNDING SCENARIO
6.14 CASE STUDY ANALYSIS
- 6.14.1 NUTRIGENOMIX - CANADA, GENETIC TEST-BASED NUTRITION PLANS
- 6.14.2 ZOE - UK, MICROBIOME & METABOLIC RESPONSE TESTING
- 6.14.3 HABIT (ACQUIRED BY VIOME) - USA, BLOOD BIOMARKER-BASED NUTRITION
6.15 TARIFF IMPACT ON PERSONALIZED NUTRITION MARKET
- 6.15.1 INTRODUCTION
- 6.15.2 KEY TARIFF RATES
- 6.15.3 DISRUPTIONS IN PERSONALIZED NUTRITION INDUSTRY
- 6.15.4 PRICE IMPACT ANALYSIS
- 6.15.5 KEY IMPACTS ON VARIOUS REGIONS
  - 6.15.5.1 US
  - 6.15.5.2 Europe
  - 6.15.5.3 Asia Pacific
- 6.15.6 END-USE INDUSTRY-LEVEL IMPACT

7 PERSONALIZED NUTRITION MARKET, BY SOLUTION TYPE

7.1 INTRODUCTION
7.2 PRODUCTS
- 7.2.1 RISING CONSUMER DEMAND FOR PRECISION HEALTH SOLUTIONS TO INTEGRATE PERSONALIZATION WITH CONVENIENCE AND EFFICACY
- 7.2.2 PERSONALIZED SUPPLEMENTS
  - 7.2.2.1 Growing reliance on tailored supplement packs addressing deficiencies, lifestyle needs, and preventive health management
  - 7.2.2.2 Customized vitamins & minerals
  - 7.2.2.3 Probiotics and prebiotics
  - 7.2.2.4 Protein and amino acid blends
  - 7.2.2.5 Botanicals and bioactives
  - 7.2.2.6 Omega-3s & Specialty Fats
- 7.2.3 PERSONALIZED FUNCTIONAL FOODS
  - 7.2.3.1 Growing consumer preference for integrating personalization into everyday diets through foods and beverages
  - 7.2.3.2 Functional foods
  - 7.2.3.3 Custom meal kits
  - 7.2.3.4 Smart beverages
7.3 SERVICES
- 7.3.1 EXPANDING CONSUMER DEMAND FOR PERSONALIZED HEALTH SERVICES TO INTEGRATE DIAGNOSTICS, COACHING, AND INSTITUTIONAL WELLNESS PROGRAMS
- 7.3.2 TESTING & DIAGNOSTICS
  - 7.3.2.1 Foundational role of diagnostics to unlock data-driven personalization and enable scalable, science-backed solutions
  - 7.3.2.2 Genetic testing kits
  - 7.3.2.3 Microbiome testing kits
  - 7.3.2.4 Blood biomarker tests
  - 7.3.2.5 Allergy tests
- 7.3.3 COACHING & DIETICIAN CONSULTATION
  - 7.3.3.1 Rising consumer need for guided interpretation of data to drive sustainable health behavioral change
- 7.3.4 CORPORATE WELLNESS & INSURANCE LINKED PROGRAMS
  - 7.3.4.1 Preventive health economics to drive insurers and employers to embed personalized nutrition
7.4 DIGITAL TOOLS/PLATFORMS
- 7.4.1 TECHNOLOGY INTEGRATION TO TRANSFORM PERSONALIZATION INTO SCALABLE, REAL-TIME, AND INTERACTIVE CONSUMER HEALTH ECOSYSTEMS
- 7.4.2 MOBILE APPS
- 7.4.3 WEARABLES & DEVICES
- 7.4.4 ONLINE PLATFORMS
- 7.4.5 AI COACH

8 PERSONALIZED NUTRITION MARKET, BY TYPE

8.1 INTRODUCTION
8.2 ACTIVE
- 8.2.1 PRECISION, INNOVATION, AND DATA-DRIVEN INSIGHTS TO FUEL ACTIVE MEASUREMENT
8.3 STANDARD
- 8.3.1 ACCESSIBILITY, AFFORDABILITY, AND SCALABILITY TO PROPEL STANDARD MEASUREMENT ADOPTION

9 PERSONALIZED NUTRITION MARKET, BY PERSONALIZATION BASIS

9.1 INTRODUCTION
9.2 NUTRIGENOMIC
- 9.2.1 GROWING CONSUMER DEMAND FOR DNA-DRIVEN NUTRITION SOLUTIONS TO BOOST PERSONALIZED HEALTH OUTCOMES
9.3 MICROBIOME-BASED
- 9.3.1 INCREASED CONSUMER AWARENESS TO BOOST IMMUNITY AND METABOLISM
9.4 BIOMARKER
- 9.4.1 RISING DEMAND FOR REAL-TIME, EVIDENCE-BASED NUTRITION SOLUTIONS SUPPORTED BY ACCESSIBLE AT-HOME BLOOD BIOMARKER TESTING
9.5 WEARABLE-BASED
- 9.5.1 RISING ADOPTION OF WEARABLES INTEGRATING NUTRITION INSIGHTS WITH GLUCOSE, SLEEP, ACTIVITY, AND RECOVERY METRICS
9.6 BEHAVIORAL & DIETARY LOG-BASED
- 9.6.1 CONSUMER DEMAND FOR ACCESSIBLE, AFFORDABLE TOOLS TO DRIVE NUTRITION CHANGE THROUGH DIGITAL TRACKING AND BEHAVIORAL COACHING
9.7 LIFESTYLE-BASED
- 9.7.1 GROWING AWARENESS OF POPULATION-SPECIFIC NUTRIENT NEEDS ACROSS AGE, GENDER, FITNESS, AND LIFESTYLE-DRIVEN CONSUMER GROUPS

10 PERSONALIZED NUTRITION MARKET, BY APPLICATION

10.1 INTRODUCTION
10.2 GENERAL LIFESTYLE
- 10.2.1 PREVENTIVE WELLNESS & EVERYDAY HEALTH OPTIMIZATION TO DRIVE MARKET
10.3 SPORTS & FITNESS PERFORMANCE
- 10.3.1 RISING ATHLETIC PARTICIPATION AND DEMAND FOR PERFORMANCE OPTIMIZATION
10.4 WEIGHT MANAGEMENT & METABOLIC HEALTH
- 10.4.1 RISING OBESITY EPIDEMIC AND LIFESTYLE-RELATED CHRONIC DISEASES
10.5 CLINICAL NUTRITION & DISEASE MANAGEMENT
- 10.5.1 GROWING CHRONIC DISEASE BURDEN AND INTEGRATION OF DIGITAL THERAPEUTICS
10.6 LIFE STAGE & SPECIAL POPULATIONS
- 10.6.1 RISING DEMAND FOR TAILORED NUTRITION ACROSS LIFE TRANSITIONS
10.7 BEAUTY, SKIN, & LONGEVITY
- 10.7.1 RISING CONSUMER FOCUS ON HOLISTIC WELLNESS AND HEALTHY AGING

11 PERSONALIZED NUTRITION MARKET, BY END USE

11.1 INTRODUCTION
11.2 DIRECT TO CONSUMERS
- 11.2.1 CONVENIENCE AND CONSUMER ENGAGEMENT TO BOOST D2C PERSONALIZED NUTRITION
11.3 PATIENT/HEALTHCARE USERS
- 11.3.1 CLINICAL CREDIBILITY AND THERAPEUTIC VALUE TO DRIVE SEGMENT
11.4 SPORTS & FITNESS
- 11.4.1 PERFORMANCE OPTIMIZATION TO BOOST DEMAND FOR PERSONALIZED NUTRITION
11.5 CORPORATES & INSURERS
- 11.5.1 RISK MITIGATION AND WORKFORCE HEALTH TO BOOST ADOPTION

12 PERSONALIZED NUTRITION MARKET, BY BUSINESS MODEL (QUALITATIVE)

12.1 INTRODUCTION
12.2 DIRECT CONSUMERS ONE-TIME PURCHASE
12.3 SUBSCRIPTION
12.4 B2B/LICENSING

13 PERSONALIZED NUTRITION MARKET, BY REGION

13.1 INTRODUCTION
13.2 NORTH AMERICA
- 13.2.1 US
  - 13.2.1.1 Advancements in AI, availability of rich datasets, and growing public interest in personalized nutrition to drive market
- 13.2.2 CANADA
  - 13.2.2.1 Supportive healthcare policies and growing focus on long-term health to drive market
- 13.2.3 MEXICO
  - 13.2.3.1 Rapid DTC & retail expansion amid regulatory tightening and public-health demand to drive market
13.3 ASIA PACIFIC
- 13.3.1 CHINA
  - 13.3.1.1 Health-related concerns to boost consumption of personalized nutrition products
- 13.3.2 JAPAN
  - 13.3.2.1 Aging population to drive demand for personalized nutrition
- 13.3.3 INDIA
  - 13.3.3.1 Surge in cardiovascular mortality and changing trends in population demographics to drive market
- 13.3.4 AUSTRALIA & NEW ZEALAND
  - 13.3.4.1 Integrated digital health adoption and preventive care partnerships
- 13.3.5 REST OF ASIA PACIFIC
13.4 EUROPE
- 13.4.1 GERMANY
  - 13.4.1.1 Aging population to drive demand for personalized solutions
- 13.4.2 UK
  - 13.4.2.1 Increasing health consciousness among consumers to drive growth
- 13.4.3 FRANCE
  - 13.4.3.1 Increasing trend of adopting high-nutrition diets to drive market
- 13.4.4 ITALY
  - 13.4.4.1 Growing inclination of consumers toward sports nutrition to positively impact market
- 13.4.5 SPAIN
  - 13.4.5.1 Growing interest in maintaining healthy lifestyle to drive market
- 13.4.6 DENMARK
  - 13.4.6.1 Public-sector openness to preventive programs to create early institutional demand
- 13.4.7 NETHERLANDS
  - 13.4.7.1 High digital health adoption and insurer experiments enable rapid payer pathways
- 13.4.8 REST OF EUROPE
13.5 SOUTH AMERICA
- 13.5.1 ARGENTINA
  - 13.5.1.1 Strong clinical diagnostics infrastructure and physician-led nutrition culture to boost demand
- 13.5.2 BRAZIL
  - 13.5.2.1 Large consumer base and mature supplement retail ecosystem to drive market
- 13.5.3 REST OF SOUTH AMERICA
13.6 REST OF THE WORLD (ROW)
- 13.6.1 AFRICA
  - 13.6.1.1 Health system partnerships and urban premium demand to boost market
- 13.6.2 MIDDLE EAST
  - 13.6.2.1 High per-capita health spend and employer adoption to drive market

14 COMPETITIVE LANDSCAPE

14.1 OVERVIEW
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
14.3 REVENUE ANALYSIS, 2020-2024
14.4 MARKET SHARE ANALYSIS, 2024
14.5 COMPANY VALUATION AND FINANCIAL MATRIX
14.6 BRAND/PRODUCT COMPARISON
- 14.6.1 ABBOTT
- 14.6.2 MEDTRONIC
- 14.6.3 NESTLE
- 14.6.4 PRENETICS
- 14.6.5 ZOE
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 14.7.1 STARS
- 14.7.2 EMERGING LEADERS
- 14.7.3 PERVASIVE PLAYERS
- 14.7.4 PARTICIPANTS
- 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS
  - 14.7.5.1 Company footprint
  - 14.7.5.2 Region footprint
  - 14.7.5.3 Solution type footprint
  - 14.7.5.4 Application footprint
  - 14.7.5.5 End-use footprint
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 14.8.1 PROGRESSIVE COMPANIES
- 14.8.2 RESPONSIVE COMPANIES
- 14.8.3 DYNAMIC COMPANIES
- 14.8.4 STARTING BLOCKS
14.9 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 14.9.1 DETAILED LIST OF KEY START-UPS/SMES
14.10 COMPETITIVE SCENARIO AND TRENDS
- 14.10.1 PRODUCT LAUNCHES
- 14.10.2 DEALS
- 14.10.3 EXPANSIONS
- 14.10.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

15.1 PRODUCT COMPANIES
- 15.1.1 KEY PLAYERS
  - 15.1.1.1 Abbott
    - 15.1.1.1.1 Business overview
    - 15.1.1.1.2 Products/Solutions/Services offered
    - 15.1.1.1.3 Recent developments
      - 15.1.1.1.3.1 Deals
      - 15.1.1.1.3.2 Other developments
    - 15.1.1.1.4 MnM view
      - 15.1.1.1.4.1 Key strengths/Right to win
      - 15.1.1.1.4.2 Strategic choices
      - 15.1.1.1.4.3 Weaknesses/Competitive threats
  - 15.1.1.2 Nestle
    - 15.1.1.2.1 Business overview
    - 15.1.1.2.2 Products/Solutions/Services offered
    - 15.1.1.2.3 Recent developments
      - 15.1.1.2.3.1 Product launches
      - 15.1.1.2.3.2 Deals
      - 15.1.1.2.3.3 Other developments
    - 15.1.1.2.4 MnM view
      - 15.1.1.2.4.1 Key strengths/Right to win
      - 15.1.1.2.4.2 Strategic choices
      - 15.1.1.2.4.3 Weaknesses/Competitive threats
  - 15.1.1.3 Rootine
    - 15.1.1.3.1 Business overview
    - 15.1.1.3.2 Products/Solutions/Services offered
  - 15.1.1.4 Viome
    - 15.1.1.4.1 Business overview
    - 15.1.1.4.2 Products/Solutions/Services offered
    - 15.1.1.4.3 Recent developments
      - 15.1.1.4.3.1 Product launches
      - 15.1.1.4.3.2 Deals
  - 15.1.1.5 Seed Health
    - 15.1.1.5.1 Business overview
    - 15.1.1.5.2 Products/Solutions/Services offered
    - 15.1.1.5.3 Recent developments
      - 15.1.1.5.3.1 Product launches
      - 15.1.1.5.3.2 Other developments
  - 15.1.1.6 myDNA
    - 15.1.1.6.1 Business overview
    - 15.1.1.6.2 Products/Solutions/Services offered
    - 15.1.1.6.3 Recent developments
      - 15.1.1.6.3.1 Deals
  - 15.1.1.7 Superpower
    - 15.1.1.7.1 Business overview
    - 15.1.1.7.2 Products/Solutions/Services offered
    - 15.1.1.7.3 Recent developments
      - 15.1.1.7.3.1 Deals
  - 15.1.1.8 Ombre
    - 15.1.1.8.1 Business overview
    - 15.1.1.8.2 Products/Solutions/Services offered
  - 15.1.1.9 Sun Genomics
    - 15.1.1.9.1 Business overview
    - 15.1.1.9.2 Products/Solutions/Services offered
    - 15.1.1.9.3 Recent developments
      - 15.1.1.9.3.1 Deals
  - 15.1.1.10 GenoPalate
    - 15.1.1.10.1 Business overview
    - 15.1.1.10.2 Products/Solutions/Services offered
    - 15.1.1.10.3 Recent developments
      - 15.1.1.10.3.1 Product launches
      - 15.1.1.10.3.2 Deals
- 15.1.2 OTHER PLAYERS
  - 15.1.2.1 Nature's Way
    - 15.1.2.1.1 Business overview
    - 15.1.2.1.2 Products/Solutions/Services offered
    - 15.1.2.1.3 Recent developments
      - 15.1.2.1.3.1 Deals
  - 15.1.2.2 Vitaminlab
    - 15.1.2.2.1 Business overview
    - 15.1.2.2.2 Products/Solutions/Services offered
  - 15.1.2.3 Cuure
    - 15.1.2.3.1 Business overview
    - 15.1.2.3.2 Products/Solutions/Services offered
  - 15.1.2.4 Thorne Healthtech
    - 15.1.2.4.1 Business overview
    - 15.1.2.4.2 Products/Solutions/Services offered
    - 15.1.2.4.3 Recent developments
      - 15.1.2.4.3.1 Deals
  - 15.1.2.5 Vitagene
    - 15.1.2.5.1 Business overview
    - 15.1.2.5.2 Products/Solutions/Services offered
15.2 SERVICE COMPANIES
- 15.2.1 KEY PLAYERS
  - 15.2.1.1 23andMe
    - 15.2.1.1.1 Business overview
    - 15.2.1.1.2 Products/Solutions/Services offered
    - 15.2.1.1.3 Recent developments
      - 15.2.1.1.3.1 Product launches
      - 15.2.1.1.3.2 Deals
    - 15.2.1.1.4 MnM View
      - 15.2.1.1.4.1 Key strengths/Right to win
      - 15.2.1.1.4.2 Strategic choices
      - 15.2.1.1.4.3 Weaknesses/Competitive threats
  - 15.2.1.2 Medtronic
    - 15.2.1.2.1 Business overview
    - 15.2.1.2.2 Products/Solutions/Services offered
    - 15.2.1.2.3 Recent developments
      - 15.2.1.2.3.1 Deals
    - 15.2.1.2.4 MnM view
      - 15.2.1.2.4.1 Key strengths/right to win
      - 15.2.1.2.4.2 Strategic choices
      - 15.2.1.2.4.3 Weaknesses/Competitive threats
  - 15.2.1.3 Prenetics
    - 15.2.1.3.1 Business overview
    - 15.2.1.3.2 Products/Solutions/Services offered
    - 15.2.1.3.3 Recent developments
      - 15.2.1.3.3.1 Product launches
      - 15.2.1.3.3.2 Deals
    - 15.2.1.3.4 MnM View
      - 15.2.1.3.4.1 Key strengths/Right to win
      - 15.2.1.3.4.2 Strategic choices
      - 15.2.1.3.4.3 Weaknesses Competitive threats
  - 15.2.1.4 Zoe
    - 15.2.1.4.1 Business overview
    - 15.2.1.4.2 Products/Solutions/Services offered
    - 15.2.1.4.3 Recent developments
      - 15.2.1.4.3.1 Other developments
15.3 OTHER PLAYERS
- 15.3.1 INSIDE TRACKER
  - 15.3.1.1 Business overview
  - 15.3.1.2 Products/Solutions/Services offered
  - 15.3.1.3 Recent developments
    - 15.3.1.3.1 Product launches
    - 15.3.1.3.2 Deals
    - 15.3.1.3.3 Other developments
- 15.3.2 NUTRIGENOMIX
  - 15.3.2.1 Business overview
  - 15.3.2.2 Products/Solutions/Services offered
  - 15.3.2.3 Recent developments
    - 15.3.2.3.1 Deals
- 15.3.3 SUGGESTIC
  - 15.3.3.1 Business overview
  - 15.3.3.2 Products/Solutions/Services offered
- 15.3.4 LEVELS
  - 15.3.4.1 Business overview
  - 15.3.4.2 Products/Solutions/Services offered
- 15.3.5 OVIVA
  - 15.3.5.1 Business overview
  - 15.3.5.2 Products/Solutions/Services offered
- 15.3.6 NOOM
  - 15.3.6.1 Business overview
  - 15.3.6.2 Products/Solutions/Services offered
  - 15.3.6.3 Recent developments
    - 15.3.6.3.1 Product launches
    - 15.3.6.3.2 Deals
- 15.3.7 CAREPREDICT
- 15.3.8 SELFDECODE
- 15.3.9 NUTRIGENIE
- 15.3.10 SEASON HEALTH
- 15.3.11 ALBA HEALTH

16 ADJACENT AND RELATED MARKETS

16.1 INTRODUCTION
16.2 LIMITATIONS
16.3 PRECISION NUTRITION MARKET
- 16.3.1 MARKET DEFINITION
- 16.3.2 MARKET OVERVIEW
16.4 DIETARY SUPPLEMENTS MARKET
- 16.4.1 MARKET DEFINITION
- 16.4.2 MARKET OVERVIEW

17 APPENDIX

17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS